首页> 美国政府科技报告 >Magnetic Resonance Spectroscopy (MRS) of Prostatic Fluids for Early Detection of Prostate Cancer
【24h】

Magnetic Resonance Spectroscopy (MRS) of Prostatic Fluids for Early Detection of Prostate Cancer

机译:用于早期检测前列腺癌的前列腺液的磁共振波谱(mRs)

获取原文

摘要

In this study, the metabolic profiles of expressed prostatic secretions (EPS) from 52 men with prostate cancer (PCa) and from 26 healthy controls were analyzed using quantitative proton nuclear magnetic resonance spectroscopy (1H-NMRS). The metabolites quantified included citrate, spermine, myo-inositol, lactate, alanine, phosphocholine, glutamine, acetate, and hydroxybutyrate. Logistic regression (LR) was used to model the risk of PCa based on metabolite concentrations while adjusting for age. The LR models indicated that the absolute concentrations of citrate, myo-inositol, and spermine were highly predictive of PCa and inversely related to the risk of PCa. The areas under the receiver operating characteristic curves (AUROC) for citrate, myo-inositol and spermine were 0.89, 0.87, and 0.79, respectively. At 90% sensitivity, these metabolites had specificities of 74%, 51% and 34%, respectively. The LR analysis indicated that absolute levels of these three metabolites were independent of age. The results indicate that citrate, myo- inositol and spermine are potentially important markers of PCa in human EPS. Further, the absolute concentration of these metabolites in EPS appears to be independent of age, increasing the potential utility of these markers due to elimination of age as a confounding variable.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号